文献速递呼吸衰竭与机械通气心脑血管急症

HACOR量表预测急性心源性肺水肿患者无创通气失败的前瞻性观察研究

Evaluation of HACOR scale as a predictor of non-invasive ventilation failure in acute cardiogenic pulmonary oedema patients: A prospective observational study.
PubMed 文献 · Am J Emerg Med · 2024-02-04
一句话结论急性心源性肺水肿患者无创通气启动后1小时HACOR评分>5可预测无创通气失败(AUC 0.73,敏感度53.7%,特异度83.2%)。

本研究为前瞻性观察研究,连续纳入急诊科因急性心源性肺水肿需要无创通气的221例患者,评估HACOR评分对无创通气失败的预测能力。结果54例(24.4%)发生无创通气失败;无创通气启动后1小时HACOR评分>5为最佳界值(AUC 0.73,敏感度53.7%,特异度83.2%)。作为HACOR组成部分的呼吸频率和心率未显示为显著预测因子;急性冠脉综合征、急性肾损伤、合并充血性心力衰竭及ROX指数为其他显著预测因子。作者认为HACOR量表在无创通气启动后1小时测量可预测无创通气失败,界值>5可作为有用的临床决策支持工具,但临床决定及时有创机械通气时还应考虑急性冠脉和急性肾损伤诊断、基础充血性心力衰竭及ROX指数。

要点

  • 急性心源性肺水肿患者无创通气启动后1小时HACOR评分>5预测无创通气失败:AUC 0.73,敏感度53.7%,特异度83.2%。
  • 221例急性心源性肺水肿患者中54例(24.4%)无创通气失败。
  • 作为HACOR评分组成部分的呼吸频率和心率未显示为显著预测因子。
  • 其他显著预测无创通气失败的因子包括急性冠脉综合征、急性肾损伤、合并充血性心力衰竭及ROX指数。
  • 作者认为HACOR评分>5可作为急性心源性肺水肿患者临床决策支持工具,但决定及时有创机械通气时还应考虑上述其他因素。

适用人群与场景

  • 急诊科连续纳入的因急性心源性肺水肿需要无创通气的患者。

诊断标准与关键阈值

  • HACOR评分>5用于预测无创通气失败,最佳评估时间为无创通气启动后1小时。

研究设计与关键结果

  • 研究类型为前瞻性观察研究,纳入221例急性心源性肺水肿需要无创通气的急诊患者,54例(24.4%)发生无创通气失败。
  • 无创通气启动后1小时HACOR评分>5预测无创通气失败的AUC为0.73,敏感度53.7%,特异度83.2%。
  • 作为HACOR评分组成部分的呼吸频率和心率未显示为显著预测因子。
  • 其他显著预测无创通气失败的因子包括急性冠脉综合征、急性肾损伤、合并充血性心力衰竭及ROX指数。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,无创通气启动后1小时HACOR评分>5可作为急性心源性肺水肿患者临床决策支持工具。
  • 作者认为,临床决定及时有创机械通气时还应考虑就诊时急性冠脉综合征和急性肾损伤诊断、基础充血性心力衰竭及ROX指数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND IMPORTANCE: Acute cardiogenic pulmonary oedema (ACPO) is a common indication for non-invasive ventilation (NIV) in the emergency department (ED). HACOR score of >5 is used to predict NIV failure. The predictive ability of HACOR may be affected by altered physiological parameters in ACPO patients due to medications or comorbidities.

OBJECTIVES: To validate the HACOR scale in predicting NIV failure among acute cardiogenic pulmonary oedema (ACPO) patients.

DESIGN, SETTINGS AND PARTICIPANTS: This is a prospective, observational study of consecutive ACPO patients requiring NIV admitted to the ED.

OUTCOME MEASURE AND ANALYSIS: Primary outcome was the ability of the HACOR score to predict NIV failure. Clinical, physiological, and HACOR score at baseline and at 1 h, 12 h and 24 h were analysed. Other potential predictors were assessed as secondary outcomes.

MAIN RESULTS: A total of 221 patients were included in the analysis. Fifty-four (24.4%) had NIV failure. Optimal HACOR score was >5 at 1 h after NIV initiation in predicting NIV failure (AUC 0.73, sensitivity 53.7%, specificity 83.2%). As part of the HACOR score, respiratory rate and heart rate were not found to be significant predictors. Other significant predictors of NIV failure in ACPO patients were acute coronary syndrome, acute kidney injury, presence of congestive heart failure as a comorbid, and the ROX index.

CONCLUSIONS: The HACOR scale measured at 1 h after NIV initiation predicts NIV failure among ACPO patients with acceptable accuracy. The cut-off level > 5 could be a useful clinical decision support tool in ACPO patient. However, clinicians should consider other factors such as the acute coronary and acute kidney diagnosis at presentation, presence of underlying congestive heart failure and the ROX index when clinically deciding on timely invasive mechanical ventilation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chong CY, Bustam A, Noor Azhar M, et al. Evaluation of HACOR scale as a predictor of non-invasive ventilation failure in acute cardiogenic pulmonary oedema patients: A prospective observational study. Am J Emerg Med. 2024. PMID: 38330879. doi:10.1016/j.ajem.2024.01.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。